Elvis and Eminem rights holders are suing Suno
THE SO WHAT
Music AI is moving from abstract copyright debates to targeted 'soundalike' litigation around marquee catalogs like Elvis and Eminem—this is where case law on stylistic mimicry will get written. If you're building or buying generative audio, you now need a real IP posture: training data provenance, opt-out handling, and artist-style controls are no longer optional paperwork.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIPartnering with Edelbyte: Data Infrastructure That Keeps Up With AI's Curiosity
If agents are going to hammer your internal systems with orders of magnitude more queries than humans ever did, the real constraint becomes data infra cost and latency, not model quality. Teams building agents should be budgeting for a new class of OLAP-style infra like Edelbyte’s, not assuming the existing warehouse can take the load.
Applied AIGoogle and Microsoft among those signing up to OpenAI's plan for a new website crawling standard — including opting-out of internet scraping
A shared robots-style standard for 'no training' across Google, Microsoft, OpenAI, and Anthropic turns model training data into a governed resource, not a free good. Operators running content sites should treat this as a pricing and leverage moment—decide now whether you want to opt out, negotiate access, or eventually charge for high-value corpora.
Applied AISources: John Ternus wants more urgency in Apple's AI efforts, pushing Craig Federighi to move beyond Siri AI tweaks to agentic and other advanced capabilities
If Apple leadership is explicitly pushing from “Siri tweaks” to agentic capabilities, the default UX on a billion-plus devices is being re-scoped from Q&A to task execution. If you build consumer apps in Apple’s ecosystem, assume background agents and delegated workflows become a first-class surface and design for being called—not tapped.
Applied AITencent AI chief warns models will soon pose biology risks, SCMP reports
When a major lab’s chief scientist says AI models may soon pose biology risks comparable to current cyber risks, the bar for internal governance and red-teaming just moved. If you touch life sciences, chemicals, or bio data, assume regulators and counterparties will start asking for concrete AI misuse controls, not just generic security language.